U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07465965) titled 'A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults' on Jan. 28.
Brief Summary: The specific aim of this study is to examine the Safety, Tolerability and Pharmacokinetic of Semaglutide Nasal Spray compared with placebo and positive control in Adult Overweight or Obese Participants.
Study Start Date: March 02
Study Type: INTERVENTIONAL
Condition:
Overweight
Obesity
Intervention:
DRUG: Semaglutide Nasal Spray
WL1006
DRUG: Placebo
WL1006
DRUG: Semaglutide Injection
Wegovy(R)
Recruitment Status: RECRUITING
Sponsor: Shanghai World Leader Pharmaceutical Co., Ltd.
Published by HT Digital Content Service...